Regeneron Pharmaceuticals, Inc. (REGN) Management at Cantor Fitzgerald Virtual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/20
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/14/20
RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron's REGN-COV2 Investigational Antibody Cocktail in the UKPRNewsWire • 09/14/20
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Citi's 15th Annual BioPharma Virtual Conference (Transcript)Seeking Alpha • 09/09/20
Kaskela Law LLC Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) and Encourages Long-Term REGN Stockholders to Contact the FirmPRNewsWire • 09/05/20
Regeneron (REGN) Down 7.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/04/20
Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be presented at ESMOPRNewsWire • 09/03/20
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.GlobeNewsWire • 09/01/20
COVID-19 Treatments: Remdesivir Disappoints, Antiviral SPL7013 And Monoclonal Antibodies Interesting For Prevention/Early-Stage TreatmentSeeking Alpha • 08/27/20